About
Portfolio
Team
Press
Home
About
Portfolio
Team
Press
Contact
Contact
EN
中文
English
中文
English
Search
Search
Hankang Portfolio | TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma Valued up to $985 Million
Hankang Portfolio | Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160
Hankang Portfolio | Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
1
2
>
